skip to main content

Valproate pregnancy prevention — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardCNS TherapeuticsValproate pregnancy preventionGPhC CRA

A 23-year-old woman taking sodium valproate for epilepsy has no recent Pregnancy Prevention Programme documentation in the pharmacy record. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Confirm PPP arrangements before supply and refer if unclear

Valproate is highly teratogenic and strict pregnancy prevention and specialist review requirements apply. This makes confirm ppp arrangements before supply and refer if unclear the single best answer in this scenario. The other options would either miss the key safety issue, delay appropriate review, or fail to meet the relevant clinical or professional requirement.

Reference: https://www.pharmacyregulation.org/registration-assessment#stage-8-order-55